News AI-discovered candidates show promise in ALS Candidates slow down motor neurone death in patient samples.
News BenevolentAI to power small molecule drug discovery Deal with MRCT will look for potential new drug targets and candidates.
News Janssen licenses drugs to artificial intelligence company BenevolentAI's Judgment Augmented Cognition System will help develop the new drugs.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
